ProfileGDS5822 / ILMN_1246295
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 69% 74% 69% 66% 79% 71% 62% 64% 69% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 146.369
GSM1276600PDAC Late Ablation Control 284.474
GSM1276601PDAC Late Ablation Control 365.469
GSM1276602PDAC Late Ablation 136.666
GSM1276603PDAC Late Ablation 2136.179
GSM1276604PDAC Late Ablation 365.471
GSM1303940PDAC Late Ablation_anti-CTLA4 13162
GSM1303941PDAC Late Ablation_anti-CTLA4 243.864
GSM1303942PDAC Late Ablation_anti-CTLA4 363.469